You are here

Article Text

Article menu
Download PDFPDF
Daring discourse
The world needs our science: broadening the research pipeline in anesthesiology
  1. Meredith C B Adams1 and
  2. Stavros G Memtsoudis2,3
  1. 1 Department of Anesthesiology, Wake Forest Baptist Health, Winston-Salem, North Carolina, USA
  2. 2 Department of Anesthesiology, Critical Care & Pain Management, Hospital for Special Surgery, New York, New York, USA
  3. 3 Department of Anesthesiology, Paracelsus Medical University, Salzburg, Austria
  1. Correspondence to Dr Meredith C B Adams, Anesthesiology, Wake Forest Baptist Health, Winston-Salem, North Carolina, USA; meredith.adams{at}wakehealth.edu

Abstract

Anesthesiologists are innovative and adaptable problem solvers. Despite these talents, our field is still working to consistently develop and support the translation of innovation and creativity into productive scientists. This article is focused on opening the discussion on identifying the gaps and move toward developing a sustainable and diverse research pipeline.

  • education
  • regional anesthesia
  • chronic pain

https://doi.org/10.1136/rapm-2020-102029

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Twitter @meredithadamsmd, @sgmemtsoudis

    • Contributors Conception or design of the work, drafting the article, critical revision of the article and final approval of the version to be published: both authors.

    • Funding MCBA is supported by National Institutes of Health funding through the NIH K08 EB022631, U24 NS115708 and R33 DA046085.

    • Competing interests SGM: no COI but discloses: co-owner: Centauros Healthcare Analytics and Consulting, LLC (Rumson, New Jersey), owner: SGM Consulting LLC (Rumson, New Jersey) and investor and Advisor: HATH (Bedford Hills, New York) and Parvizi Surgical Innovations LLC (Philadelphia, Pennsylvania).

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; externally peer reviewed.